Global Bronchodilators Market 2017-2021

Global Bronchodilators Market 2017-2021

  • July 2017 •
  • 83 pages •
  • Report ID: 5028501 •
  • Format: PDF
About Bronchodilators

Bronchodilators are a type of medication, which make breathing easy by relaxing the muscles in the lungs and widening the airways (bronchi). They are used to treat the breathing problems, majorly asthma and COPD.
Short-acting bronchodilators are the first-line therapy, which is widely used in bronchodilators. These agents have a short-term (2-4 hours) duration of action and therefore require multiple dosages.
Whereas, long-acting bronchodilators, which are introduced recently, have an extended period of action. They reduce the process of multiple dosages. Therefore, they are more effective than the short-term bronchodilators.

Technavio’s analysts forecast the global bronchodilators market to grow at a CAGR of 4.78% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global bronchodilators market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Bronchodilators Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GlaxoSmithKline

Other prominent vendors
• ALK-Abello
• Amgen
• Array BioPharma
• Astellas Pharma
• Atopix Therapeutics
• CHIESI Farmaceutici
• Dynavax Technologies
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• MediciNova
• Mitsubishi Tanabe Pharma
• Mundipharma International
• Nycomed Pharma
• Oxagen
• Pearl Therapeutics
• Pharmaxis
• Pulmagen Therapeutics
• Regeneron Pharmaceuticals
• Revalesio
• Sanofi
• SolAeroMed
• Stallergenes Greer
• sterna biologicals
• Synairgen
• Theron Pharmaceuticals
• UCB Pharma
• Verona Pharma

Market driver
• Market potential toward mAb
• For a full, detailed list, view our report

Market challenge
• Increased preference for CAM
• For a full, detailed list, view our report

Market trend
• Innovative technologies for drug delivery
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


We are very sorry, but an error occurred.
Please contact if the problem remains.